Literature DB >> 7688755

Comparative humoral responses to human immunodeficiency virus type 1-p24gag linear B-cell epitopes among individuals showing atypical western immunoblotting reactions and implications for diagnosis.

J C Lallement1, J P Vendrell, P Corbeau, J Ducos, M Segondy, A Escande, V Robert-Hebmann, F Jean, J Reynes, A Serre.   

Abstract

Serum specimens from 25 individuals with an isolated human immunodeficiency virus type 1 (HIV-1) core antigen reactivity in a Western immunoblot test were examined for their reactivities with HIV-1 virions, control cellular antigens, HIV-1-Bru p24gag recombinant protein (p24gag), and a panel of 22 p24gag-derived peptides. The results were as follows: (i) serum specimens from eight HIV-1-uninfected subjects did bind to virions but failed to bind to p24gag; (ii) sera from 13 HIV-1-uninfected subjects and from one HIV-2-infected patient reacted with HIV-1 virions and p24gag but failed to bind to any of the peptides expressing major p24gag epitopes, and (iii) 3 serum specimens obtained from one neonate carrying anti-HIV-1 maternal antibody and from two HIV-1-infected subjects who had seroconverted during the study reacted with HIV-1 virions, p24gag, and one or more peptides containing the major p24gag epitopes. Our data suggest that the combination of p24gag and appropriate peptides could be useful for resolution when atypical Western immunoblot results are encountered.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7688755      PMCID: PMC265655          DOI: 10.1128/jcm.31.7.1903-1907.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  A highly defective HIV-1 strain isolated from a healthy Gabonese individual presenting an atypical western blot.

Authors:  T Huet; M C Dazza; F Brun-Vézinet; G E Roelants; S Wain-Hobson
Journal:  AIDS       Date:  1989-11       Impact factor: 4.177

2.  Follow-up testing and notification of anti-HIV Western blot atypical (indeterminant) donors.

Authors:  S Kleinman; L Fitzpatrick; K Secord; D Wilke
Journal:  Transfusion       Date:  1988 May-Jun       Impact factor: 3.157

3.  The case for wider use of testing for HIV infection.

Authors:  F S Rhame; D G Maki
Journal:  N Engl J Med       Date:  1989-05-11       Impact factor: 91.245

4.  Absence of HIV infection in blood donors with indeterminate western blot tests for antibody to HIV-1.

Authors:  J B Jackson; K L MacDonald; J Cadwell; C Sullivan; W E Kline; M Hanson; K J Sannerud; S L Stramer; N J Fildes; S Y Kwok
Journal:  N Engl J Med       Date:  1990-01-25       Impact factor: 91.245

5.  Investigation of atypical western blot (immunoblot) reactivity involving core proteins of human immunodeficiency virus type.

Authors:  S L Josephson; N S Swack; M T Ramirez; W J Hausler
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

6.  An early postinfection signal mediated by monoclonal anti-beta 2 microglobulin antibody is responsible for delayed production of human immunodeficiency virus type 1 in peripheral blood mononuclear cells.

Authors:  P Corbeau; C Devaux; F Kourilsky; J C Chermann
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

7.  Expression of human endogenous retroviral sequences in peripheral blood mononuclear cells of healthy individuals.

Authors:  P Medstrand; M Lindeskog; J Blomberg
Journal:  J Gen Virol       Date:  1992-09       Impact factor: 3.891

8.  Antibody response in primary human immunodeficiency virus infection.

Authors:  H Gaines; M von Sydow; A Sönnerborg; J Albert; J Czajkowski; P O Pehrson; F Chiodi; L Moberg; E M Fenyö; B Asjö
Journal:  Lancet       Date:  1987-05-30       Impact factor: 79.321

9.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

10.  Expression of Ley antigen in human immunodeficiency virus-infected human T cell lines and in peripheral lymphocytes of patients with acquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC).

Authors:  M Adachi; M Hayami; N Kashiwagi; T Mizuta; Y Ohta; M J Gill; D S Matheson; T Tamaoki; C Shiozawa; S Hakomori
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

View more
  1 in total

1.  Anti-human immunodeficiency virus type 1 antibodies of noninfected subjects are not related to autoantibodies occurring in systemic diseases.

Authors:  R Kämmerer; P Bürgisser; P C Frei
Journal:  Clin Diagn Lab Immunol       Date:  1995-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.